[p53].
Living with p53, dying of p53.
p53 and chemosensitivity.
p53 in dermatology.
PCNA and p53.
p53 and apoptosis.
The p53 network.
Papillomavirus and p53.
[P53 and cancers].
p53 and angiogenesis.
P53 and angiogenesis.
p53 and apoptosis.
p53 and atherosclerosis.
Mini p53.
p53 and chemosensitivity.
The p53 pathway.
[Oncoprotein p53].
p53 In endometriosis.
Beyond p53.
[The p53 gene].
Pivoting on p53.
Down with p53!
[Suntanning and p53].
p53 at a glance.
Sirtuins and p53.
p53 and metabolism.
PINTing for p53.
Building p53.
p53-Induced apoptosis and inhibitors of p53.
We analyzed tumors from p53-/-, p53+/-, and p53+/+ littermates.
Comparisons of p53(+/+) and p53(-/-) mice established that the apoptosis is p53 independent.
p53 alpha-Helix mimetics antagonize p53/MDM2 interaction and activate p53.
Cleaved PARP was found in p53+/+ and p53+/- eyes, but not in p53-/- mice.
The expression of p53 and phosphorylated p53 (p-p53) was detected by immunohistochemistry.
Inhibition of P53-MDM2 interaction stabilizes P53 protein and activates P53 pathway.
In addition, p53ser246-transgenic mice (p53+/+, p53*; p53+/-, p53*; and p53-/-, p53*) have a greatly increased number of hepatocytes in the G1 phase.
There was increasing divergence of p53+ and p53- tumors over time.
Control of p53 turnover is critical to p53 function.
Overexpression of p53 is considered to be predictive of mutations of the p53 gene.
Signaling to p53: breaking the MDM2-p53 circuit.
p53 transactivation through various p53-responsive elements.
CD also induces apoptosis in p53+/+, but not in p53-/- cells.
p53 and p53-regulated genes in bladder cancer.
The NER was reduced in p53-/- keratinocytes as compared with p53+/+ keratinocytes.
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.
The binding of Mdm2 to p53 is required for targeting p53 for degradation.
p300/CBP/p53 interaction and regulation of the p53 response.
Comparative study of the p53-mdm2 and p53-MDMX interfaces.
Mdm2, an oncoprotein, inhibits p53 and promotes p53 degradation.
p53 and p53-regulated genes in bladder cancer.
p53 protein detection is usually a synonym for p53 mutation.
Main protein of apoptosis is p53, especially phosphorylation of p53.
There were no mutations in the p53 gene, and p53 was functionally intact.
Mutation of this p53 consensus sequence abolished binding of p53.
Anti-p53 antibodies and p53 protein expression in cholangiocarcinoma.
Computational protein chemistry of p53 and p53 peptides.
A549 is p53 proficient and H1299 is p53 null mutant.
The p53 network: p53 and its downstream genes.
The p53 knowledgebase: an integrated information resource for p53 research.
p53-Dependent and p53-independent activation of autophagy by ARF.
p53 isoforms can regulate p53 transcriptional activity.
The p53 family consists of p53, p73 and p63.
Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.
Updates on p53: modulation of p53 degradation as a therapeutic approach.
CIMD depends on p73, a homolog of p53, but not on p53.
CIMD depends on p73, a homologue of p53, but not on p53.
p53 alteration (nuclear p53 overexpression) was detected by immunohistochemistry.
There are many isoforms of p53, p63 and p73 (the p53 family).
Mutant p53 rescue and modulation of p53 redox state.
p53 chromatin epigenetic domain organization and p53 transcription.
WWP1 associates with p53 and induces p53 ubiquitylation.
The overexpression of p53 was determined by immunohistochemistry with antihuman p53 antibody.